These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

727 related articles for article (PubMed ID: 25873042)

  • 41. Dopamine and opioid systems adaptation in alcoholism revisited: Convergent evidence from positron emission tomography and postmortem studies.
    Hansson AC; Gründer G; Hirth N; Noori HR; Spanagel R; Sommer WH
    Neurosci Biobehav Rev; 2019 Nov; 106():141-164. PubMed ID: 30243576
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stimulant medications: how to minimize their reinforcing effects?
    Volkow ND
    Am J Psychiatry; 2006 Mar; 163(3):359-61. PubMed ID: 16513852
    [No Abstract]   [Full Text] [Related]  

  • 43. Dopamine ups and downs in vulnerability to addictions: a neurodevelopmental model.
    Leyton M; Vezina P
    Trends Pharmacol Sci; 2014 Jun; 35(6):268-76. PubMed ID: 24794705
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Altered neural correlates of reward and loss processing during simulated slot-machine fMRI in pathological gambling and cocaine dependence.
    Worhunsky PD; Malison RT; Rogers RD; Potenza MN
    Drug Alcohol Depend; 2014 Dec; 145():77-86. PubMed ID: 25448081
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Individual differences and vulnerability to drug addiction: a focus on the endocannabinoid system.
    Sagheddu C; Melis M
    CNS Neurol Disord Drug Targets; 2015; 14(4):502-17. PubMed ID: 25714966
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anhedonia, Reduced Cocaine Reward, and Dopamine Dysfunction in a Rat Model of Posttraumatic Stress Disorder.
    Enman NM; Arthur K; Ward SJ; Perrine SA; Unterwald EM
    Biol Psychiatry; 2015 Dec; 78(12):871-9. PubMed ID: 26115790
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A role for mesencephalic dopamine in activation: commentary on Berridge (2006).
    Robbins TW; Everitt BJ
    Psychopharmacology (Berl); 2007 Apr; 191(3):433-7. PubMed ID: 16977476
    [No Abstract]   [Full Text] [Related]  

  • 48. The debate over dopamine's role in reward: the case for incentive salience.
    Berridge KC
    Psychopharmacology (Berl); 2007 Apr; 191(3):391-431. PubMed ID: 17072591
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The genetic basis of individual differences in reward processing and the link to addictive behavior and social cognition.
    Yacubian J; Büchel C
    Neuroscience; 2009 Nov; 164(1):55-71. PubMed ID: 19446009
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased risk for developing gambling disorder under the treatment with pramipexole, ropinirole, and aripiprazole: A nationwide register study in Sweden.
    Wolfschlag M; Håkansson A
    PLoS One; 2021; 16(6):e0252516. PubMed ID: 34061895
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Brain mechanisms of drug reward and euphoria.
    Wise RA; Bozarth MA
    Psychiatr Med; 1985; 3(4):445-60. PubMed ID: 2893431
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reward, interrupted: Inhibitory control and its relevance to addictions.
    Jentsch JD; Pennington ZT
    Neuropharmacology; 2014 Jan; 76 Pt B(0 0):479-86. PubMed ID: 23748054
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Natural and drug rewards act on common neural plasticity mechanisms with ΔFosB as a key mediator.
    Pitchers KK; Vialou V; Nestler EJ; Laviolette SR; Lehman MN; Coolen LM
    J Neurosci; 2013 Feb; 33(8):3434-42. PubMed ID: 23426671
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Involvement of the brain histaminergic system in addiction and addiction-related behaviors: a comprehensive review with emphasis on the potential therapeutic use of histaminergic compounds in drug dependence.
    Brabant C; Alleva L; Quertemont E; Tirelli E
    Prog Neurobiol; 2010 Nov; 92(3):421-41. PubMed ID: 20638439
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Beer flavor provokes striatal dopamine release in male drinkers: mediation by family history of alcoholism.
    Oberlin BG; Dzemidzic M; Tran SM; Soeurt CM; Albrecht DS; Yoder KK; Kareken DA
    Neuropsychopharmacology; 2013 Aug; 38(9):1617-24. PubMed ID: 23588036
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of mesoaccumbens dopamine in nicotine dependence.
    Balfour DJ
    Curr Top Behav Neurosci; 2015; 24():55-98. PubMed ID: 25638334
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Putative COVID- 19 Induction of Reward Deficiency Syndrome (RDS) and Associated Behavioral Addictions with Potential Concomitant Dopamine Depletion: Is COVID-19 Social Distancing a Double Edged Sword?
    Blum K; Cadet JL; Baron D; Badgaiyan RD; Brewer R; Modestino EJ; Gold MS
    Subst Use Misuse; 2020; 55(14):2438-2442. PubMed ID: 32957797
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ghrelin amplifies the nicotine-induced dopamine release in the rat striatum.
    Palotai M; Bagosi Z; Jászberényi M; Csabafi K; Dochnal R; Manczinger M; Telegdy G; Szabó G
    Neurochem Int; 2013 Oct; 63(4):239-43. PubMed ID: 23831084
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Update in the clinic of addictions: learning and dopamine].
    Pérez JM; Orellana G
    Rev Med Chil; 2007 Mar; 135(3):384-91. PubMed ID: 17505586
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Computer and video game addiction-a comparison between game users and non-game users.
    Weinstein AM
    Am J Drug Alcohol Abuse; 2010 Sep; 36(5):268-76. PubMed ID: 20545602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.